Effect of hydroxyurea on physical fitness indices in children with sickle cell anemia

Pediatric Hematology and Oncology

Volumn 28, Issue 1, 2011, Pages 43-50

  Wali, Yasser A ^a   Moheeb, Hisham ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

hemoglobinopathies; pediatrics; sickle cell disease

Indexed keywords

FAT; HEMOGLOBIN; HYDROXYUREA;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ABSOLUTE NEUTROPHIL COUNT; ADOLESCENT; AEROBIC EXERCISE; ARTICLE; BODY FAT DISTRIBUTION; BODY HEIGHT; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG USE; DRUG WITHDRAWAL; EXERCISE TEST; EXERCISE TOLERANCE; FITNESS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HAND STRENGTH; HEART RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MUSCLE STRENGTH; NEUTROPHIL COUNT; PATIENT MONITORING; RUNNING; SCHOOL CHILD; SICKLE CELL ANEMIA; SIDE EFFECT; SKINFOLD THICKNESS; TREADMILL EXERCISE; TREATMENT DURATION;

ADOLESCENT; ANEMIA, SICKLE CELL; BODY HEIGHT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; EXERCISE TEST; HEART RATE; HUMANS; HYDROXYUREA; MALE; PHYSICAL FITNESS; RUNNING;

EID: 79952137523     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.524278     Document Type: Article

References (30)

1. Serjeant GR. Sickle cell disease. Lancet. 1997;350:725-730.
2. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343-1360. (Pubitemid 39335827)
3. Roseff SD. Sickle cell disease: a review. Immunohematology. 2009;25:67-74.
4. Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle-cell syndromes: results of a 17-year, single center trial (LaSHS). Blood. 2010;115:2354-2363.
5. Strouse JJ, Lanzkron S, Beach MC, et al. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics. 2008;122:1332-1342.
6. Thornburg CD, Dixon N, Burgett S, et al. A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer. 2009;52:609-615.
7. Segal JB, Strouse JJ, Beach MC, et al. Hydroxyurea for the treatment of sickle cell disease. Evid Rep Technol Assess (Full Rep). 2008;(165):1-95.
8. Moheeb H, Wali YA, El-Sayed MS. Physical fitness indices and anthropometrics profiles in schoolchildren with sickle cell trait/disease. Am J Hematol. 2007;82:91-97. (Pubitemid 46155270)
9. Peterson MJ, Czerwinski SA, Siervogel RM. Development and validation of skinfold-thickness prediction equations with a 4-compartment model. Am J Clin Nutr. 2003;77:1186-1191. (Pubitemid 44858434)
10. Durnin JVGA, Wormersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged 16 to 72 years. Br J Nutr. 1974;32:77-97.
11. Cepeda ML, Allen FH, Cepeda NJ, Yang YM. Physical growth, sexual maturation, body image and sickle cell disease. J Natl Med Assoc. 2000;92:10-14.
12. Soliman AT, el Banna NM, alSalmi IA, et al. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease. Metabolism. 1997;46:1241-1245.
13. Buchowski MS, Chen KY, Byrne DA, Wang WC. Equation to estimate resting energy expenditure in adolescents with sickle cell anemia. Am J Clin Nutr. 2002;76:1335-1344. (Pubitemid 35416570)
14. Buchowski MS, Townsend KM, Chen KY. Patterns of energy expenditure in adolescents with sickle cell anemia. J Pediatrics. 2002;140:86-92. (Pubitemid 34117472)
15. Williams RA, Mackert PP, Fletcher LA, et al. Comparison of energy prediction equations with measured resting energy expenditure in children with sickle cell disease. J Am Diet Assoc. 2002;102:956-961.
16. Holocomb WR. Stretching and warm-up. In: Baechle TR, Earle RW, eds. Essentials of Strength Training and Conditioning. Champaign IL: Human Kinetics; 2000:321-329.
17. Vichinsky EP. Hydroxyurea in children: present and future. Semin Hematol. 1997;34(3 Suppl 3):22-29.
18. Charache S. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol. 1997;34(3 Suppl 3):15-21.
19. Ballas SK, Dover GJ, Charache S. Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo. Am J Hematol. 1989;32:104-111. (Pubitemid 19218212)
20. Fathallah H, Atweh GF. Induction of fetal hemoglobin in the treatment of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2006:58-62.
21. Lou TF, Singh M, Mackie A, et al. Hydroxyurea generates nitric oxide in human erythroid cells: mechanisms for gamma-globin gene activation. Exp Biol Med (Maywood). 2009;234:1374-1382.
22. Heeney MM, Ware RE. Hydroxyurea for children with sickle cell disease. Hematol Oncol Clin North Am. 2010;24:199-214.
23. Ballas SK, Marcolina MJ, Dover GJ, Barton FB. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea. Br J Haematol. 1999;105:491-496. (Pubitemid 29232176)
24. Odièvre MH, Bony V, Benkerrou M, et al. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease. Haematologica. 2008;93:502-510.
25. Cartron JP, Elion J. Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus Clin Biol. 2008;15:39-50.
26. Anderson N. Hydroxyurea therapy: improving the lives of patients with sickle cell disease. Pediatr Nurs. 2006;32:541-543.
27. Potteiger JA. Aerobic endurance exercise prescription. In: Baechle TR, Earle RW, eds. Essentials of strength Training and Conditioning. Champaign IL: Human Kinetics; 2000:495-508.
28. Ware RE, Aygun B. Advances in the use of hydroxyurea. Hematology Am Soc Hematol Educ Program. 2009:62-69.
29. Lee MT, Rosenzweig EB, Cairo MS. Pulmonary hypertension in sickle cell disease. Clin Adv Hematol Oncol. 2007;5:645-653, 585.
30. Olnes M, Chi A, Haney C, et al. Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea. Am J Hematol. 2009;84:530-532.